Form 4: Tandem Diabetes Care Executive Rick Carpenter Reports Stock Transactions

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On June 17, 2024, Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, exercised restricted stock units (RSUs) converting them into 406 shares of common stock.
• The same day, 145 shares were withheld by Tandem Diabetes Care to satisfy tax obligations related to the vesting of the RSUs at a price of $45.33.
• Following these transactions, Carpenter directly owns 11,236 shares of Tandem Diabetes Care common stock and 2,436 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral filing, simply reporting required transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Tandem Diabetes Care. It provides transparency into the transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives, ensuring transparency in stock transactions.
• Similar filings are made by executives at comparable companies in the medical device industry, such as Insulet (PODD) and Dexcom (DXCM), when they exercise stock options or RSUs.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive stock transactions.
• The tax withholding impacts the executive's personal finances.

Key Dates